1. CureDuchenne’s Early Funding Projects Take a Big Step Forward Today

    Posted on June 29, 20153:58 pm

      FDA Accepts NDA for Drisapersen, the First-Ever Treatment for Duchenne Muscular Dystrophy to Reach this Milestone in the U.S., and Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen  It is a big day for the Duchenne community.  It is also a proud moment for CureDuchenne.  Today, BioMarin announced that the U.S. Food and Read more »

  2. CureDuchenne’s Debra Miller Wins OCBJ Women in Business Award

    Posted on June 26, 20157:56 pm

      On behalf of team CureDuchenne, we are ecstatic to announce that our co-founder and our daily inspiration Debra Miller was presented with the esteemed Women in Business Award to honor her career in finding a cure for Duchenne muscular dystrophy. The Orange County Business Journal’s Women in Business Award is presented to five outstanding Read more »

  3. Capricor Therapeutics – Webinar on Upcoming Clinical Trial for Cardiac Indication in Duchenne

    Posted on June 18, 201510:34 pm

      There has been a lot of recent Duchenne research news lately.  As a community, we are glad to see a variety of research programs moving forward with positive results. This provides hope for all those that live with Duchenne and their families. Duchenne is a complex disease and will require a variety of treatments Read more »